Subscribe for PTCOG-NA Updates
Stereotactic Body Radiotherapy (SBRT) & Oligometastatic Disease
Dr. Daniel Gomez attended college at the University of Virginia and went to medical school at the University of California, San Francisco. He completed a residency in radiation oncology at Memorial Sloan Kettering Cancer Center. He then joined as a faculty member at MD Anderson Cancer Center. On service, he published multiple clinical trials and translational studies on the diagnosis, treatment, and therapeutic toxicity in the setting of thoracic malignancies. He led the first report demonstrating the benefit of local ablative therapy in the setting of oligometastatic non-small cell lung cancer and served as director of the thoracic radiation oncology service for 3 years. In 2019, Dr. Gomez joined the faculty of Memorial Sloan Kettering Cancer Center as the director of the thoracic radiation oncology service at MSCS, as well as recently becoming the Vice Chair of Clinical Operations in the Department of Radiation Oncology. He continues to publish clinical, translational, and operational studies in the department.
Imaging & Image-Guided Radiation Therapy (IGRT)
Immunotherapy / RBE / Heavy Particles
Chandan Guha, MBBS, PhD, is the Vice Chair of Radiation Oncology at the Albert Einstein College of Medicine (Einstein) and Montefiore Medical Center and Professor of Pathology, Urology, and Radiation Oncology at Einstein. He is also the founding director of Einstein’s Institute for Onco-physics. Dr. Guha’s research work is in the fields of immunology, radiation oncology, and liver diseases, and has been focused on two areas: 1. Immunotherapeutic approaches for cancer therapy, and 2. Use of regenerative strategies to repopulate injured tissue by use of stem cell-based technologies. As a clinician, he is also involved in treating prostate and liver cancers and is an investigator in several worldwide clinical trials.